Autosomal Dominant Polycystic Kidney Disease News and Research

RSS
Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

New discoveries on polycystin-1 can lead to novel kidney disease treatment

New discoveries on polycystin-1 can lead to novel kidney disease treatment

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

UCSB research: Rapamycin drug, a potential treatment for ADPKD

UCSB research: Rapamycin drug, a potential treatment for ADPKD

Researchers visualize vasculature within native liver cyst walls of human ADPKD patients

Researchers visualize vasculature within native liver cyst walls of human ADPKD patients

Measuring quality of life in patients with hereditary kidney disease

Measuring quality of life in patients with hereditary kidney disease

MRI provides an early alert for polycystic kidney disease

MRI provides an early alert for polycystic kidney disease

Rapamycin (sirolimus) may be effective in treating kidney disease

Rapamycin (sirolimus) may be effective in treating kidney disease

Cellular discovery suggests possibilities for drug therapy for kidney disease

Cellular discovery suggests possibilities for drug therapy for kidney disease

New treatment trials for autosomal dominant polycystic kidney disease

New treatment trials for autosomal dominant polycystic kidney disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.